Moleculin Biotech updates dilution sensitivity in S-1/A; net proceeds $9.1M

Filed July 31, 2026 · Compared to S-1/A Jul 30, 2026 · ~1 min read

Key Changes

• high

  Dilution sensitivity figures revised: a $0.10 offering price change now moves net tangible book value per share by $0.05, down from $0.61/$0.52.

  Dilution verify on EDGAR →
• high

  Share count sensitivity also revised: a 1,000,000 share change now moves net tangible book value per share by $0.08/$(0.10), down from $0.65/$0.47.

  Dilution verify on EDGAR →
• medium

  Common stock outstanding before offering increased to 7,100,713 from 5,336,350, and after offering to 11,666,923 from 9,902,560.

  Offering verify on EDGAR →